Literature DB >> 17073005

Childhood lupus nephritis: 12 years experience from North India.

Surjit Singh1, Ranjana Minz, Ritambhra Nada, Kusum Joshi.   

Abstract

Twenty-five children (20 girls and five boys) with lupus nephritis seen over last 12 years, were evaluated. Twenty underwent renal biopsies. Cyclophosphamide pulse therapy was used in eight patients (median 14 pulses, range 6-16) with severe disease or histological class. Four of these eight patients became asymptomatic (class IV, 2; class II and V, one each) after 4-24 months. Two (class III and IV, one each) died after a stable chronic renal insufficiency for almost a decade; one died 9 months after diagnosis (class IV). Of the 12 patients who underwent biopsy but were not treated with cyclophosphamide, six became asymptomatic during follow up (class II, four patients; class VI and V, one each), two continued to have proteinuria (class II), one (class IV) had raised ESR but normal renal functions and two died (class IV). Three of the five patients who were not biopsied remained asymptomatic; two were lost to follow up. Mortality was seen only with class III (one patient) or class IV (five patients) lesions. Outcome in lupus nephritis depends largely on WHO histological class. Cyclophosphamide pulse therapy is associated with a favorable outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073005     DOI: 10.1007/s00296-005-0036-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Immunosuppressive therapy in lupus nephritis.

Authors:  D D'Cruz; M J Cuadrado; F Mujic; M F Tungekar; N Taub; M Lloyd; M A Khamashta; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1997 May-Jun       Impact factor: 4.473

2.  Cyclophosphamide in lupus nephritis: a controlled trial.

Authors:  A D Steinberg; H B Kaltreider; P J Staples; E J Goetzl; N Talal; J L Decker
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

3.  Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Authors:  D T Boumpas; H A Austin; E M Vaughn; J H Klippel; A D Steinberg; C H Yarboro; J E Balow
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

4.  Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults.

Authors:  I Pande; N G Sekharan; S Kailash; S S Uppal; R R Singh; A Kumar; A N Malaviya
Journal:  Lupus       Date:  1993-04       Impact factor: 2.911

5.  Mortality patterns in childhood lupus--10 years' experience in a developing country.

Authors:  S Singh; L Kumar; K Joshi
Journal:  Clin Rheumatol       Date:  2002-11       Impact factor: 2.980

Review 6.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  Systemic lupus erythematosus--survival patterns. Experience with 609 patients.

Authors:  D J Wallace; T Podell; J Weiner; J R Klinenberg; S Forouzesh; E L Dubois
Journal:  JAMA       Date:  1981-03-06       Impact factor: 56.272

8.  Childhood systemic lupus erythematosus in south India.

Authors:  A N Chandrasekaran; C P Rajendran; S Ramakrishnan; R Madhavan; M Parthiban
Journal:  Indian J Pediatr       Date:  1994 May-Jun       Impact factor: 1.967

9.  Lupus nephritis in children--a review of 167 patients.

Authors:  L Y Yang; W P Chen; C Y Lin
Journal:  Pediatrics       Date:  1994-09       Impact factor: 7.124

10.  Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

Authors:  T J Lehman; D D Sherry; L Wagner-Weiner; D K McCurdy; H M Emery; D B Magilavy; A Kovalesky
Journal:  J Pediatr       Date:  1989-06       Impact factor: 4.406

View more
  5 in total

1.  Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciarán M Duffy; Chantal Bernard; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2007-10-24       Impact factor: 3.714

Review 2.  Prevalence and burden of pediatric-onset systemic lupus erythematosus.

Authors:  Sylvia Kamphuis; Earl D Silverman
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

3.  Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India.

Authors:  Jasmina Ahluwalia; Surjit Singh; Shano Naseem; Deepti Suri; Amit Rawat; Anju Gupta; Joseph Masih; Sunil Bose
Journal:  Rheumatol Int       Date:  2013-04-07       Impact factor: 2.631

4.  Childhood lupus nephritis: 12 years of experience from a developing country's perspective.

Authors:  Moumita Samanta; Madhumita Nandi; Rakesh Mondal; Avijit Hazra; Sumatra Sarkar; Tapas Sabui; Chanchal Kumar Kundu; Arnab Biswas
Journal:  Eur J Rheumatol       Date:  2017-09-01

5.  Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India.

Authors:  D Sircar; G Sircar; R Waikhom; A Raychowdhury; R Pandey
Journal:  Indian J Nephrol       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.